Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Invitae Announces Completion of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional
02/18/2015- SAN FRANCISCO --(BUSINESS WIRE)-- Invitae Corporation (NYSE:NVTA), a genetic information company, announced today the closing of its initial public... Read more
Invitae announces pricing of initial public offering of common stock
SAN FRANCISCO, February 11, 2015 - Invitae Corporation (NYSE: NVTA), a genetic information company, announced today the pricing of its... Read more